Transdermal Patch Options Equivalent to 1 mg Oral Estradiol and 100 mg Oral Progesterone
For transdermal estradiol, use a 50 μg/day patch (applied twice weekly), which provides comparable systemic estradiol levels to 1 mg oral estradiol; for progesterone, there is no FDA-approved transdermal progesterone patch available in the US, so you must use oral micronized progesterone 100 mg daily or consider combination patches containing estradiol with a progestogen.
Estradiol Patch Dosing
The 50 μg/day transdermal estradiol patch is the appropriate equivalent to 1 mg oral estradiol 1. This is based on the principle that oral estradiol undergoes significant first-pass hepatic metabolism, resulting in 5-fold higher circulating estrone levels and 10- to 20-fold higher estrone sulfate compared to transdermal administration at comparable doses 1. The transdermal route delivers more physiologic estradiol-to-estrone ratios.
Available transdermal estradiol patches include:
- 50 μg/day patches - applied twice weekly (most common formulation, available in 32 countries) 2
- 100 μg/day patches - for women requiring higher doses (younger surgical menopause, premature ovarian insufficiency) 1
- 25 μg/day patches - for lower dose needs (available in 20 countries) 2
The 50 μg/day patch maintains steady-state estradiol levels around 35 pg/mL with minimal fluctuation (0.65), reaching therapeutic concentrations within 12 hours of application 3. In contrast, 1 mg oral estradiol produces large pulses with 12-fold higher average concentrations (418 pg/mL) and significant fluctuation (3.68) 3.
Progesterone Options
There is no standalone transdermal progesterone patch approved for menopausal hormone therapy in the US. Your options are:
Option 1: Separate Estradiol Patch + Oral Progesterone (Preferred)
- Estradiol 50 μg/day patch (twice weekly)
- Plus oral micronized progesterone 100 mg daily for continuous combined therapy 4
- This provides adequate endometrial protection with the metabolic advantages of transdermal estrogen 1
Option 2: Combination Estradiol-Progestogen Patches
Available combination patches include 4:
- Estradiol-levonorgestrel patches
- Estradiol-norethindrone acetate patches
Important caveat: These contain synthetic progestogens (not progesterone), which have different side effect profiles and may cause premenstrual-type symptoms including mood changes, bloating, and fluid retention 4.
Option 3: Vaginal Progesterone (Alternative)
- Vaginal micronized progesterone 100 mg daily (days 14-25 of each 28-day cycle for sequential therapy, or daily for continuous therapy)
- Provides adequate endometrial protection with fewer systemic side effects 5
- Better bleeding control and treatment compliance compared to oral progesterone 5
- However, limited published data for menopausal use specifically 4
Clinical Advantages of Transdermal Estradiol
Transdermal estradiol is preferable for patients with: 1
- VTE risk factors
- Hypertension
- Hypertriglyceridemia
- Obesity or metabolic syndrome
- Diabetes
- History of gallbladder disease
This is because transdermal administration avoids first-pass hepatic effects that increase SHBG, thyroid-binding globulin, triglycerides, inflammatory markers (C-reactive protein), and procoagulant factors 1.
Practical Considerations
- Patch application: The 50 μg/day patch is typically changed twice weekly (every 3-4 days) 6, 3
- Monitoring: Estradiol levels are not routinely measured unless symptoms fail to improve with dose escalation 1
- Thyroid patients: If the patient has hypothyroidism, transdermal estradiol does not significantly affect thyroid function, whereas oral estradiol increases total T4 and may require levothyroxine dose adjustment 7
- Endometrial protection: In women with a uterus, progestogen is mandatory to prevent endometrial hyperplasia and cancer 1, 4
Common Pitfall
Do not assume transdermal progesterone patches are readily available—they are not standard formulations in the US market. Recent research on compound estradiol-progesterone patches shows promise 8, but these are investigational and not commercially available. Always plan to use oral or vaginal progesterone alongside transdermal estradiol patches.